Abcellera Biologics Inc(ABCL-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low5.33
Day High5.74
Open:5.61
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Tipranks
Analysts Offer Insights on Healthcare Companies: Zymeworks (ZYME), Amylyx Pharmaceuticals Inc (AMLX) and AbCellera Biologics (ABCL)
Tipranks
AbCellera, Jazz Partner on Next-Generation Cancer Antibodies
Business Wire
Jazz Pharmaceuticals and AbCellera Announce Collaboration to Discover Next-Generation T-cell Engaging Multispecific Antibodies
Tipranks
AbCellera Shareholders Back Directors, Auditors, Executive Pay
Business Wire
AbCellera Appoints Dr. Victor Sandor to its Board of Directors
MarketBeat
AbCellera Biologics Bets on Hot Flash Antibody as Pipeline Pivot Gains Steam
MarketBeat.com
Tipranks
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS), AbCellera Biologics (ABCL) and Indivior (INDV)
Tipranks
AbCellera Biologics Bets Big on 2026 Trial Catalysts
Tipranks
Analysts Offer Insights on Healthcare Companies: Phreesia (PHR), AbCellera Biologics (ABCL) and PACS Group Inc (PACS)
Tipranks
Analysts’ Opinions Are Mixed on These Healthcare Stocks: West Pharmaceutical Services (WST), CVRx (CVRX) and AbCellera Biologics (ABCL)
Tipranks
Analysts Offer Insights on Healthcare Companies: Ceribell, Inc. (CBLL) and AbCellera Biologics (ABCL)
MarketBeat
AbCellera Biologics Q1 Earnings Call Highlights
MarketBeat.com
Motley Fool
AbCellera (ABCL) Q1 2026 Earnings Transcript
Business Wire
AbCellera Reports Q1 2026 Business Results & Announces Positive Interim Phase 1 Clinical Data for ABCL635
Business Wire
AbCellera to Present at Upcoming Investor Conferences in May and June 2026
Tipranks
Analysts Offer Insights on Healthcare Companies: AbCellera Biologics (ABCL) and Revolution Medicines (RVMD)
Tipranks
Analysts Offer Insights on Healthcare Companies: Align Tech (ALGN), AbCellera Biologics (ABCL) and Pulmonx (LUNG)
Tipranks
Analysts Offer Insights on Healthcare Companies: AbCellera Biologics (ABCL) and Fennec Pharmaceuticals (FENC)
Business Wire
AbCellera to Highlight Phase 1 Clinical Data for ABCL635 During Upcoming First Quarter 2026 Earnings Call

Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635 and ABCL575. AbCellera Biologics Inc. is based in Vancouver, Canada.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.